NIH-sponsored trial data offers further evidence to help inform mpox treatment decisions.
A NEW mutant strain of mpox discovered in the Democratic Republic of Congo could be better at spreading between people, ...
A NIH-led trial found tecovirimat ineffective in reducing mpox lesion healing time or pain relief. The study was halted in 2024, with findings presented at CROI 2025.
The Citizen on MSN3d
Tanzania confirms two mpox casesDar es Salaam. The Ministry of Health has confirmed two cases of Mpox, marking the first time the disease has been reported ...
The patient, a 29-year-old woman who lives in the metropolitan region of São Paulo, had contact with a relative who had been ...
Six weeks after Rwanda-backed rebels captured the eastern Congolese cities of Goma and Bukavu, the region is facing a setback ...
THE government has intensified surveillance and precautionary measures against Mpox after confirming two cases ...
The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...
The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback